The breast lesion localization market is primarily driven by the rising incidence of breast cancer, the increasing number of breast cancer screening programs, and improved reimbursement scenario. This, in turn, is attributed to the growth in the aging population and changing lifestyles, which have increased the overall possibility of cancer occurrence.
According to the American Cancer Society, breast cancer is the second-leading cause of cancer-related deaths in women across the globe. Globally, there has been significant growth in the number of breast cancer cases.
With age, the risk of developing breast cancer increases. Aging increases multipotent progenitors (a type of adult stem cell at the root of many breast cancers) and decreases the number of myoepithelial cells, which line the breast’s milk-producing luminal cells and serve as tumor suppressors.
Download PDF Brochure @ https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=35768623
Developing economies, such as India, China, Brazil, South Korea, Turkey, Russia, and South Africa, offer high growth opportunities for the major players operating in the breast lesion localization market. A large population base—especially in India and China—offers a sustainable market for entire medical and surgical devices.
Exposure to radiation has several short-term and long-term side effects, which usually occur within six months or even after a year of exposure. Some of the common side-effects after radiation exposure are mild pain or discomfort around the breast, skin damage, swelling or inflammation of the breast or surrounding tissues, loss of hair in the armpit or chest, and fatigue.
The APAC market is projected to grow at the highest CAGR during the forecast period. Growth in this market can primarily be attributed to the rapidly increasing patient population, increasing healthcare expenditure, improving healthcare infrastructure.
Key Market Players breast lesion localization market are Hologic, Inc. (US), Becton, Dickinson and Company (US), Merit Medical Systems (US), Leica Biosystems Nussloch GmbH (US), Argon Medical Devices (US), Laurane Medical LLC (France), Endomagnetics Ltd. (UK), Intramedical Imaging, LLC (US), Isoaid (US), Surgiceye GmbH (Germany), Ranfac Corp. (US), Mermaid Medical Group (Denmark), Izi Medical Products, LLC (US).